Holen Sie sich die Stockscreener-App
224.38
1.51%
3.33
Handel nachbörslich:
224.38
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$221.05
Offen:
$222.38
24-Stunden-Volumen:
365.69K
Relative Volume:
0.50
Marktkapitalisierung:
$16.12B
Einnahmen:
$2.90B
Nettoeinkommen (Verlust:
$467.20M
KGV:
35.22
EPS:
6.37
Netto-Cashflow:
$306.90M
1W Leistung:
-0.80%
1M Leistung:
+0.04%
6M Leistung:
-33.46%
1J Leistung:
-31.82%
1-Tages-Spanne:
$219.46
$224.72
1-Wochen-Bereich:
$219.46
$233.84
52-Wochen-Spanne:
$187.43
$352.33
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Vergleichen Sie WST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
224.38 | 16.25B | 2.90B | 467.20M | 306.90M | 6.37 |
|
ISRG
Intuitive Surgical Inc
|
512.64 | 189.29B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
178.27 | 50.30B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
86.92 | 43.02B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
254.25 | 37.53B | 5.02B | 1.31B | 1.56B | 8.91 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
Strategy To YieldBoost West Pharmaceutical Services From 0.4% To 13.2% Using Options - Nasdaq
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory - Insider Monkey
How West Pharmaceutical Services Inc. stock performs during market volatility2x Return Forecast - Newser
Why West Pharmaceutical Services Inc. stock attracts strong analyst attentionFree Stock Index Interpretation - Newser
What makes West Pharmaceutical Services Inc. stock price move sharplyProven High Yield Signals - Newser
Drug Development Inputs & Services Stocks Q1 Results: Benchmarking West Pharmaceutical Services (NYSE:WST) - Yahoo Finance
Is West Pharmaceutical Services (WST) a Great Business Unfairly Sold Off by the Market? - Insider Monkey
Here's Why West Pharmaceutical Services (NYSE:WST) Can Manage Its Debt Responsibly - simplywall.st
Cambridge Investment Research Advisors Inc. Sells 281 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Services to Announce Q2 2025 Results and Host Live Conference Call - MSN
Sustainable Pharmaceutical Packaging Market to Reach USD 299.95 billion by 2032 - newstrail.com
Allspring Global Investments Holdings LLC Sells 251 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
WEST ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
West Pharmaceutical Services’ Q2 2025 Earnings: What to Expect - MSN
West to Host Second-Quarter 2025 Conference Call - The Malaysian Reserve
DAVENPORT & Co LLC Has $499,000 Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
West Pharmaceutical Services, Inc. Sued for Securities Law - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming DeadlinesWST - PR Newswire
Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Reminds Investors of July 7, 2025 - ACCESS Newswire
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Victoria Advocate
West Pharmaceutical Services Faces Securities Class Action Lawsuit Allegations. - AInvest
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for InvestorsContact The Gross Law Firm - cnhinews.com
Vontobel Holding Ltd. Sells 206 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsWST - PR Newswire
Investors in West Pharmaceutical Services, Inc. (WST): Protect Your RightsContact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Sequoia Financial Advisors LLC Trims Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
Robeco Institutional Asset Management B.V. Raises Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - PR Newswire
Deadline Soon: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
User - FinancialContent
WST Deadline: WST Investors with Losses in Excess of $100K Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit - PR Newswire
The Best Healthcare Stocks to Buy - Morningstar
KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth - Investing.com
Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline - ACCESS Newswire
KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth By Investing.com - Investing.com UK
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - FinancialContent
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - StreetInsider
Is West Pharmaceutical Services Stock Underperforming The Nasdaq? - Barchart.com
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm - Morningstar
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
2025-06-16 | Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action | NYSE:WST | Press Release - Stockhouse
Deadline Alert: West Pharmaceutical Services, Inc. (WST) - GlobeNewswire
Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView
West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline - ACCESS Newswire
The Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025WST - PR Newswire
Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class ActionContact Levi & Korsinsky - ACCESS Newswire
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):